CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit

4
1
Favorite

CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit

Bloomberg2024-10-11

Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Xiong68
·2024-10-11
Share your opinion about this news…
Reply
Like
Report

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2474277245?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-11 09:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474277245","market":"us","top_or_hot":-1,"title":"CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit","media":"Bloomberg","content":"<div>\n<p>Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCD&R Nears €15 billion Deal for Sanofi Consumer Health Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-11 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit","article_id":"2474277245","we_media_id":null,"thumbnails":[],"rights":{"source":"lsy1584095487587","url":"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2474277245","pubTimestamp":1728609300,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","0O59.UK":"赛诺菲","SNY":"赛诺菲安万特","BK4007":"制药","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股"},"translate_title":"CD&R接近150亿欧元收购赛诺菲消费者健康部门","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNY":0.9,"0O59.UK":1},"content_text":"Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in what would be one of the largest European transactions this year, people familiar with the matter said.The private equity firm has seen off interest from rival PAI Partners for the Opella unit, according to the people, who asked not to be identified discussing confidential information. A deal could be announced in the coming days, they said.Sanofi is likely going to retain a minority stake in the Opella business, which sells over-the-counter products including Cenovis vitamins, DulcoLax constipation relief and Icy Hot pain relief gel, according to the people.While discussions are at an advanced stage, they could still be delayed or falter, the people said. A representative for Sanofi wasn’t available for comment. Representatives for CD&R and PAI Partners declined to comment.A deal would cap a yearlong effort by Sanofi to split its consumer health business as the company looks to generate better long-term value for cutting-edge therapies, particularly in immunology or vaccines. It would also rank among the largest deals in Europe this year, Bloomberg-compiled data show, and be a sign of a revival in health-care dealmaking on the continent.CD&R, which raised a record $26 billion buyout fund last year, has been an active investor in France in recent years. In July, the firm teamed up with Permira and offered to take cybersecurity company Exclusive Networks SA private. It’s also an investor in Mobilux, one of the largest home equipment retailers in France.Founded in 1978, CD&R has been investing across North America and Europe, focusing on sectors such as business services, consumer, financial services, health care and technology. In Europe’s health-care industry, it backs companies including contract packaging and clinical manufacturing firm Sharp.Earlier this year, CD&R appointed Adam Karol from Silver Lake as a partner to help lead its health-care investment team. The buyout firm also named Leslie Starr, who had stints at PepsiCo Inc. and Procter & Gamble, as operating adviser focusing on consumer businesses.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[{"id":358683239837760,"gmtCreate":1728609324687,"gmtModify":1728610476151,"author":{"id":"4137211471035692","authorId":"4137211471035692","name":"Xiong68","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[{"badgeId":"cbe1c45c584340f3bd9ae6c77e0e9981-1","name":"Academy Experiencer","description":"5 lessons learned","smallImgUrl":"https://community-static.tradeup.com/news/c2660a1935bd2105e97c9915619936c3","bigImgUrl":"https://community-static.tradeup.com/news/fb5ae275631fb96a92d475cdc85d2302","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"idStr":"4137211471035692","authorIdStr":"4137211471035692"},"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/358683239837760","repostId":2474277245,"repostType":2,"repost":{"id":"2474277245","kind":"highlight","pubTimestamp":1728609300,"share":"https://ttm.financial/m/news/2474277245?lang=en_US&edition=fundamental","pubTime":"2024-10-11 09:15","market":"us","language":"en","title":"CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2474277245","media":"Bloomberg","summary":"Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire","content":"<div>\n<p>Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CD&R Nears €15 billion Deal for Sanofi Consumer Health Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCD&R Nears €15 billion Deal for Sanofi Consumer Health Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-11 09:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4585":"ETF&股票定投概念","0O59.UK":"赛诺菲","SNY":"赛诺菲安万特","BK4007":"制药","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股"},"source_url":"https://www.bloomberg.com/news/articles/2024-10-10/cd-r-said-near-15-billion-deal-for-sanofi-consumer-health-unit","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2474277245","content_text":"Private equity firm sees off rival bidder PAI PartnersSanofi is likely to retain a minority stake in Opella unitPhotographer: Nathan Laine/BloombergClayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in what would be one of the largest European transactions this year, people familiar with the matter said.The private equity firm has seen off interest from rival PAI Partners for the Opella unit, according to the people, who asked not to be identified discussing confidential information. A deal could be announced in the coming days, they said.Sanofi is likely going to retain a minority stake in the Opella business, which sells over-the-counter products including Cenovis vitamins, DulcoLax constipation relief and Icy Hot pain relief gel, according to the people.While discussions are at an advanced stage, they could still be delayed or falter, the people said. A representative for Sanofi wasn’t available for comment. Representatives for CD&R and PAI Partners declined to comment.A deal would cap a yearlong effort by Sanofi to split its consumer health business as the company looks to generate better long-term value for cutting-edge therapies, particularly in immunology or vaccines. It would also rank among the largest deals in Europe this year, Bloomberg-compiled data show, and be a sign of a revival in health-care dealmaking on the continent.CD&R, which raised a record $26 billion buyout fund last year, has been an active investor in France in recent years. In July, the firm teamed up with Permira and offered to take cybersecurity company Exclusive Networks SA private. It’s also an investor in Mobilux, one of the largest home equipment retailers in France.Founded in 1978, CD&R has been investing across North America and Europe, focusing on sectors such as business services, consumer, financial services, health care and technology. In Europe’s health-care industry, it backs companies including contract packaging and clinical manufacturing firm Sharp.Earlier this year, CD&R appointed Adam Karol from Silver Lake as a partner to help lead its health-care investment team. The buyout firm also named Leslie Starr, who had stints at PepsiCo Inc. and Procter & Gamble, as operating adviser focusing on consumer businesses.","news_type":1,"symbols_score_info":{"SNY":0.9,"0O59.UK":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":false,"newsSizeData":{"likeSize":4,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}